Emvolon and Montauk Renewables Partner to Convert Methane Emissions into Carbon-Negative Fuel

Emvolon, an MIT spin-off specializing in converting greenhouse gas emissions into carbon-negative fuels and chemicals, has announced a partnership with Montauk Renewables, Inc. (NASDAQ: MNTK), a renewable energy company focused on biogas recovery and conversion. The collaboration will leverage Emvolon’s…

Read MoreEmvolon and Montauk Renewables Partner to Convert Methane Emissions into Carbon-Negative Fuel

Korea Zinc’s Key Position in Global Semiconductor Supply Chain Raises Concerns Over Possible Acquisition

Concerns Arise Over MBK Partners and Young Poong’s Hostile Takeover Bid Targeting Korea Zinc’s Role in Semiconductor Supply Chain A hostile takeover attempt led by MBK Partners and Young Poong is raising alarms about potential risks to the global semiconductor…

Read MoreKorea Zinc’s Key Position in Global Semiconductor Supply Chain Raises Concerns Over Possible Acquisition

Mitsubishi Chemical Expands Ion Exchange Resin Production for Semiconductor Ultrapure Water

The Mitsubishi Chemical Group (MCG Group) has announced plans to enhance its production capacity of ion exchange resins, essential for generating ultrapure water used in semiconductor manufacturing. This expansion will take place at Mitsubishi Chemical’s Kyushu-Fukuoka Plant located in Kitakyushu…

Read MoreMitsubishi Chemical Expands Ion Exchange Resin Production for Semiconductor Ultrapure Water

Bayer and MOMA Therapeutics Form Collaborative Licensing Agreement in Oncology

Bayer and MOMA Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing a new generation of precision therapeutics, have announced a collaboration through an option and exclusive license agreement. This partnership aims to develop and commercialize a small molecule oncology…

Read MoreBayer and MOMA Therapeutics Form Collaborative Licensing Agreement in Oncology

Merck Inaugurates €290 Million Biosafety Testing Facility in Rockville, Maryland

Merck, a leading science and technology company, has officially opened its new €290 million biosafety testing facility in Rockville, Maryland, USA. This facility is essential for biosafety testing and analytical development, which are crucial for the drug development and commercialization…

Read MoreMerck Inaugurates €290 Million Biosafety Testing Facility in Rockville, Maryland